Rapid Diagnostic Kits Market for Indian Ocean Region Countries Worth $1.75 Billion by 2029
Meticulous Research®—a leading global market research company, published a research
report titled, ‘Rapid Diagnostic
Kits Market for Indian Ocean Region Countries by Product
(Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious
Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospitals, Diagnostic
Labs)—Forecast to 2029.’
Download sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5418?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=05-01-2024
According to this latest publication from
Meticulous Research®, the rapid
diagnostics kits market for Indian Ocean region countries is expected to
register a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029. The
growth of this market is driven by the growing demand for PoC diagnostics, the
high prevalence of chronic diseases coupled with the increasing geriatric
population, the high prevalence of infectious diseases, the increasing need for
rapid decision-making, and the outbreak of the COVID-19 pandemic.
The Rapid
Diagnostics Kits Market for Indian Ocean Region Countries is segmented by
Product (Professional Kits and OTC Kits), Platform (Immunoassays, Molecular
Detection Tests, and Other Rapid Diagnostic Platforms), Application (Blood
Glucose Testing, Cardiac Metabolism Testing, Infectious Diseases Testing,
Pregnancy & Fertility Testing, Hematology Testing, Tumor/Cancer Markers
Testing, Urinalysis, Cholesterol Testing, and Other Tests), End User (Hospitals
& Clinics, Diagnostic Laboratories, Home Care/Self-testing, and Other End
Users), and Geography. The study also evaluates industry competitors and
analyzes their key growth strategies in the market.
Based on product, in 2022, the
professional kits segment is expected to account for the larger share of the
rapid diagnostic kits market in Indian Ocean region countries. The large market
share of this segment is attributed to the higher preference for PoC testing,
the high prevalence of chronic diseases, and technological advancements in
rapid diagnostics, supporting the high adoption of professional kits.
Based on platform, in 2022, the
immunoassays segment is expected to account for the largest share of the rapid
diagnostic kits market in Indian Ocean region countries. The large market share
of this segment is mainly attributed to the high prevalence of chronic and infectious
diseases, technological innovations, coupled with the advantages offered by the
rapid immunoassay tests, such as cost-effectiveness and at-home testing.
Based on application, in 2022, the
infectious diseases testing segment is expected to account for the largest
share of the rapid diagnostic kits market for Indian Ocean region countries.
Infectious diseases are transmissible or communicable illnesses that can spread
quickly and become epidemics. It is crucial to quickly diagnose initial
infections and prevent further spread through in-vitro diagnosis. The high
prevalence of infectious diseases in the countries of the Indian Ocean region
is a key factor in the large share of the segment. For instance, around 2.4
million people were infected with HIV in India in 2021.
Based on end user, in 2022, the
hospitals & clinics segment is expected to account for the largest share of
the rapid diagnostic kits market for Indian Ocean region countries. Factors
attributing to this segment's largest share include a high preference for hospitals
& clinics for primary care across the countries in the Indian Ocean region.
Quick
Buy: https://www.meticulousresearch.com/Checkout/75587733?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=05-01-2024
This research report provides a comprehensive
analysis of the rapid diagnostic kits market in France, India, Australia,
Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and
Seychelles. India is expected to grow with the fastest growth over the forecast
period. Factors contributing to the growth include the rising hospitalization
due to various diseases, the increasing geriatric population, and increasing
healthcare access & expenditure.
Key
Players:
Key
companies operating in the rapid diagnostic kits market for Indian Ocean region
countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.),
Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON
Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific
Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.),
BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc
(Ireland).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment